HIV Citation List: February 15 - February 28, 2013

PubMed citations

1. Antiviral Strategies Combining Antiretroviral Drugs with RNAi-mediated Attack on HIV-1 and Cellular Co-factors. Boutimah, F., J.J. Eekels, Y.P. Liu, and B. Berkhout. Antiviral Research, 2013. [Epub ahead of print]. PMID[23439083].
[PubMed]. HIV_0215-022813.

2. Development of Sulphated and Naphthylsulfonated Carbosilane Dendrimers as Topical Microbicides to Prevent HIV-1 Sexual Transmission. Cordoba, E.V., E. Arnaiz, M. Relloso, C. Sanchez-Torres, F. Garcia, L. Perez-Alvarez, R. Gomez, F.J. de la Mata, M. Pion, and M.A. Munoz-Fernandez. AIDS, 2013. [Epub ahead of print]. PMID[23435291].
[PubMed]. HIV_0215-022813.

3. Antibody Conjugation Approach Enhances Breadth and Potency of Neutralization of anti-HIV-1 Antibodies and CD4-IgG. Gavrilyuk, J., H. Ban, H. Uehara, S. Sirk, K. Saye-Francisco, A. Cuevas, E. Zablowsky, A. Oza, M.S. Seaman, D.R. Burton, and C.F. Barbas, 3rd. Journal of Virology, 2013. [Epub ahead of print]. PMID[23427154].
[PubMed]. HIV_0215-022813.

4. Purification and Characterization of an Antifungal Peptide with Potent Antifungal Activity but Devoid of Antiproliferative and HIV Reverse Transcriptase Activities from Legumi secchi Beans. Lam, S.K. and T.B. Ng. Applied Biochemistry and Biotechnology, 2013. [Epub ahead of print]. PMID[23412767].
[PubMed]. HIV_0215-022813.

5. Discovery of Novel Inhibitors of LEDGF/p75-IN Protein-protein Interactions. Sanchez, T.W., B. Debnath, F. Christ, H. Otake, Z. Debyser, and N. Neamati. Bioorganic & Medicinal Chemistry, 2013. 21(4): p. 957-963. PMID[23306052].
[PubMed]. HIV_0215-022813.

6. Highly Efficient Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase by Aptamers Functionalized Gold Nanoparticles. Shiang, Y.C., C.M. Ou, S.J. Chen, T.Y. Ou, H.J. Lin, C.C. Huang, and H.T. Chang. Nanoscale, 2013. [Epub ahead of print]. PMID[23429884].
[PubMed]. HIV_0215-022813.

7. Discovery of a Small-molecule Antiviral Targeting the HIV-1 Matrix Protein. Zentner, I., L.J. Sierra, L. Maciunas, A. Vinnik, P. Fedichev, M.K. Mankowski, R.G. Ptak, J. Martin-Garcia, and S. Cocklin. Bioorganic & Medicinal Chemistry Letters, 2013. 23(4): p. 1132-1135. PMID[23305922].
[PubMed]. HIV_0215-022813.

8. Rationally Designed Multitarget anti-HIV Agents. Zhan, P. and X. Liu. Current Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23410170].
[PubMed]. HIV_0215-022813.

ISI Web of Knowledge Citations

9. Safety and Efficacy of Tenofovir/IQP-0528 Combination Gels - a Dual Compartment Microbicide for HIV-1 Prevention. Dezzutti, C.S., C. Shetler, A. Mahalingam, S.R. Ugaonkar, G. Gwozdz, K.W. Buckheit, and R.W. Buckheit. Antiviral Research, 2012. 96(2): p. 221-225. ISI[000313393800017].
[WOS]. HIV_0215-022813.

10. Preclinical Evaluation of HIV Eradication Strategies in the Simian Immunodeficiency Virus-infected Rhesus Macaque: A Pilot Study Testing Inhibition of Indoleamine 2,3-dioxygenase. Dunham, R.M., S.N. Gordon, M. Vaccari, M. Piatak, Y. Huang, S.G. Deeks, J. Lifson, G. Franchini, and J.M. McCune. AIDS Research and Human Retroviruses, 2013. 29(2): p. 207-214. ISI[000313810100002].
[WOS]. HIV_0215-022813.

11. In Vitro Profiling of the Vaginal Permeation Potential of anti-HIV Microbicides and the Influence of Formulation Excipients. Grammen, C., P. Augustijns, and J. Brouwers. Antiviral Research, 2012. 96(2): p. 226-233. ISI[000313393800018].

[WOS]. HIV_0215-022813.

12. PEGylation of a Proprotein Convertase Peptide Inhibitor for Vaginal Route of Drug Delivery: In Vitro Bioactivity, Stability and in Vivo Pharmacokinetics. Ho, H.T., T.L. Nero, H. Singh, M.W. Parker, and G.Y. Nie. Peptides, 2012. 38(2): p. 266-274. ISI[000313610600008].
[WOS]. HIV_0215-022813.

13. In Vitro Antibacterial and Antiviral Activities of Some Novel 1,3,4-Thiadiazole Derivatives. Joshi, S.D., U.A. More, S. Dixit, G.S. Gadaginamath, and V.H. Kulkarni. Indian Journal of Heterocyclic Chemistry, 2012. 22(2): p. 109-114. ISI[000314139600004].
[WOS]. HIV_0215-022813.

14. 4862F, a New Inhibitor of HIV-1 Protease, from the Culture of Streptomyces I03A-04862. Liu, X., M.L. Gan, B. Dong, T. Zhang, Y.Z. Li, Y.Q. Zhang, X.Y. Fan, Y.X. Wu, S.K. Bai, M.H. Chen, L.Y. Yu, P.Z. Tao, W. Jiang, and S.Y. Si. Molecules, 2013. 18(1): p. 236-243. ISI[000314032900017].
[WOS]. HIV_0215-022813

15. A Phenotypic Assay to Identify Chikungunya Virus Inhibitors Targeting the Nonstructural Protein nsP2. Lucas-Hourani, M., A. Lupan, P. Despres, S. Thoret, O. Pamlard, J. Dubois, C. Guillou, F. Tangy, P.O. Vidalain, and H. Munier-Lehmann. Journal of Biomolecular Screening, 2013. 18(2): p. 172-179. ISI[000313661900003].
[WOS]. HIV_0215-022813.

16. Nanoencapsulation and Characterization of Zidovudine on Poly(L-lactide) and Poly(L-lactide)-poly(ethylene glycol)-blend Nanoparticles. Mainardes, R.M. and M.P.D. Gremiao. Journal of Nanoscience and Nanotechnology, 2012. 12(11): p. 8513-8521. ISI[000313851000039].
[WOS]. HIV_0215-022813.

17. Synthesis, Spectroscopy and Computational Studies of Selected Hydroxyquinoline Carboxylic Acids and Their Selected Fluoro-, Thio-, and Dithioanalogues. Nycz, J.E. and G.J. Malecki. Journal of Molecular Structure, 2013. 1032: p. 159-168. ISI[000313601100025].
[WOS]. HIV_0215-022813.

18. Poly (4-styrenesulfonic acid-co-maleic acid) Is an Entry Inhibitor against Both HIV-1 and HSV Infections - Potential as a Dual Functional Microbicide. Qiu, M., Y. Chen, S.W. Song, H.Y. Song, Y. Chu, Z.P. Yuan, L. Cheng, D.T. Zheng, Z.W. Chen, and Z.W. Wu. Antiviral Research, 2012. 96(2): p. 138-147. ISI[000313393800008].
[WOS]. HIV_0215-022813.

19. Viral Enzymes Containing Magnesium: Metal Binding as a Successful Strategy in Drug Design. Rogolino, D., M. Carcelli, M. Sechi, and N. Neamati. Coordination Chemistry Reviews, 2012. 256(23-24): p. 3063-3086. ISI[000313475000015].
[WOS]. HIV_0215-022813.

20. SiO2 Nanoparticles as Platform for Delivery of Nucleoside Triphosphate Analogues into Cells. Vasilyeva, S.V., V.N. Silnikov, N.V. Shatskaya, A.S. Levina, M.N. Repkova, and V.F. Zarytova. Bioorganic & Medicinal Chemistry, 2013. 21(3): p. 703-711. ISI[000313696900013].
[WOS]. HIV_0215-022813.

21. Contribution of SAM and HD Domains to Retroviral Restriction Mediated by Human SAMHD1. White, T.E., A. Brandariz-Nunez, J.C. Valle-Casuso, S. Amie, L. Nguyen, B. Kim, J. Brojatsch, and F. Diaz-Griffero. Virology, 2013. 436(1): p. 81-90. ISI[000314003800010].
[WOS]. HIV_0215-022813.

22. Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification. Wielens, J., S.J. Headey, D.I. Rhodes, R.J. Mulder, O. Dolezal, J.J. Deadman, J. Newman, D.K. Chalmers, M.W. Parker, T.S. Peat, and M.J. Scanlon. Journal of Biomolecular Screening, 2013. 18(2): p. 147-159. ISI[000313661900001].
[WOS]. HIV_0215-022813.

23. Effective Inhibition of Human Immunodeficiency Virus 1 Replication by Engineered RNase P Ribozyme. Zeng, W.B., Y.C. Chen, Y. Bai, P. Trang, G.P. Vu, S.W. Lu, J.G. Wu, and F.Y. Liu. Plos One, 2012. 7(12). ISI[000313618800031].
[WOS]. HIV_0215-022813.

24. Three-dimensional Quantitative Structure-activity Relationship Models of HIV-1 Integrase Inhibitors of DKAs. Zhang, M.Q., W.N. Zhao, and S.Y. Lu. Chinese Journal of Structural Chemistry, 2012. 31(12): p. 1769-1781. ISI[000313530200012].
[WOS]. HIV_0215-022813.